b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1156954/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156954/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Respiratory Research" /><meta name="citation_title" content="Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS" /><meta name="citation_authors" content="Chun-Hua Wang, Chien-Ying Liu, Yung-Liang Wan, Chun-Liang Chou, Kuo-Hsiung Huang, Horng-Chyuan Lin, Shu-Min Lin, Tzou-Yien Lin, Kian Fan Chung, Han-Pin Kuo" /><meta name="citation_date" content="2005" /><meta name="citation_volume" content="6" /><meta name="citation_doi" content="10.1186/1465-9921-6-42" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1156954/?report=abstract" /><meta name="citation_pmid" content="15888207" /><meta name="DC.Title" content="Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Chun-Hua Wang" /><meta name="DC.Contributor" content="Chien-Ying Liu" /><meta name="DC.Contributor" content="Yung-Liang Wan" /><meta name="DC.Contributor" content="Chun-Liang Chou" /><meta name="DC.Contributor" content="Kuo-Hsiung Huang" /><meta name="DC.Contributor" content="Horng-Chyuan Lin" /><meta name="DC.Contributor" content="Shu-Min Lin" /><meta name="DC.Contributor" content="Tzou-Yien Lin" /><meta name="DC.Contributor" content="Kian Fan Chung" /><meta name="DC.Contributor" content="Han-Pin Kuo" /><meta name="DC.Date" content="2005" /><meta name="DC.Identifier" content="10.1186/1465-9921-6-42" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS" /><meta property="og:type" content="article" /><meta property="og:description" content="During the acute phase of severe acute respiratory syndrome (SARS), mononuclear cells infiltration, alveolar cell desquamation and hyaline membrane formation have been described, together with dysregulation of plasma cytokine levels. Persistent high-resolution ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156954/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1156954/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1156954/pdf/12931_2005_Article_280.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BF459E999783100000000095D095C.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC1156954</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">Respiratory Research</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Respir Res</span>. 2005; 6: 42. </span></div><div><span class="fm-vol-iss-date">Published online 2005 May 11. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1465-9921-6-42" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1465-9921-6-42</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1156954</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/15888207">15888207</a></div></div></div></div><h1 class="content-title">Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Wang%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637391231440" co-class="co-affbox">Chun-Hua Wang</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1_280</sup> <a href="/pubmed/?term=Liu%20CY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637377728080" co-class="co-affbox">Chien-Ying Liu</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1_280</sup> <a href="/pubmed/?term=Wan%20YL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637376544656" co-class="co-affbox">Yung-Liang Wan</a>,<sup>2_280</sup> <a href="/pubmed/?term=Chou%20CL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637376542736" co-class="co-affbox">Chun-Liang Chou</a>,<sup>1_280</sup> <a href="/pubmed/?term=Huang%20KH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637376540816" co-class="co-affbox">Kuo-Hsiung Huang</a>,<sup>1_280</sup> <a href="/pubmed/?term=Lin%20HC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637385669520" co-class="co-affbox">Horng-Chyuan Lin</a>,<sup>1_280</sup> <a href="/pubmed/?term=Lin%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637385667152" co-class="co-affbox">Shu-Min Lin</a>,<sup>1_280</sup> <a href="/pubmed/?term=Lin%20TY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637373789280" co-class="co-affbox">Tzou-Yien Lin</a>,<sup>3_280</sup> <a href="/pubmed/?term=Chung%20KF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637373786912" co-class="co-affbox">Kian Fan Chung</a>,<sup>4_280</sup> and  <a href="/pubmed/?term=Kuo%20HP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207" class="affpopup" co-rid="_co_idm140637390799472" co-class="co-affbox">Han-Pin Kuo</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1_280</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140637391231440"><h3 class="no_margin">Chun-Hua Wang</h3><p><sup>1_280</sup>Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Wang%20CH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Chun-Hua Wang</a></div></div><div id="_co_idm140637377728080"><h3 class="no_margin">Chien-Ying Liu</h3><p><sup>1_280</sup>Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Liu%20CY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Chien-Ying Liu</a></div></div><div id="_co_idm140637376544656"><h3 class="no_margin">Yung-Liang Wan</h3><p><sup>2_280</sup>Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Wan%20YL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Yung-Liang Wan</a></div></div><div id="_co_idm140637376542736"><h3 class="no_margin">Chun-Liang Chou</h3><p><sup>1_280</sup>Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Chou%20CL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Chun-Liang Chou</a></div></div><div id="_co_idm140637376540816"><h3 class="no_margin">Kuo-Hsiung Huang</h3><p><sup>1_280</sup>Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Huang%20KH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Kuo-Hsiung Huang</a></div></div><div id="_co_idm140637385669520"><h3 class="no_margin">Horng-Chyuan Lin</h3><p><sup>1_280</sup>Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Lin%20HC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Horng-Chyuan Lin</a></div></div><div id="_co_idm140637385667152"><h3 class="no_margin">Shu-Min Lin</h3><p><sup>1_280</sup>Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Lin%20SM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Shu-Min Lin</a></div></div><div id="_co_idm140637373789280"><h3 class="no_margin">Tzou-Yien Lin</h3><p><sup>3_280</sup>Division of Pediatric Infectious Diseases, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Lin%20TY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Tzou-Yien Lin</a></div></div><div id="_co_idm140637373786912"><h3 class="no_margin">Kian Fan Chung</h3><p><sup>4_280</sup>National Heart &#x00026; Lung Institute, Imperial College &#x00026; Royal Brompton Hospital, London, UK </p><div>Find articles by <a href="/pubmed/?term=Chung%20KF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Kian Fan Chung</a></div></div><div id="_co_idm140637390799472"><h3 class="no_margin">Han-Pin Kuo</h3><p><sup>1_280</sup>Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan </p><div>Find articles by <a href="/pubmed/?term=Kuo%20HP%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15888207">Han-Pin Kuo</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140637379348848_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140637379348848_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140637379348848_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140637379348848_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1_280"><sup>1_280</sup>Department of Thoracic Medicine II, Chang Gung Memorial Hospital, Taipei, Taiwan </div><div class="fm-affl" lang="en" id="Aff2_280"><sup>2_280</sup>Department of Diagnostic Radiology, Chang Gung Memorial Hospital, Taipei, Taiwan </div><div class="fm-affl" lang="en" id="Aff3_280"><sup>3_280</sup>Division of Pediatric Infectious Diseases, Chang Gung Memorial Hospital, Taipei, Taiwan </div><div class="fm-affl" lang="en" id="Aff4_280"><sup>4_280</sup>National Heart &#x00026; Lung Institute, Imperial College &#x00026; Royal Brompton Hospital, London, UK </div><div><span class="fm-affl">Chun-Hua Wang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.tenih.7sm@auhnuhcw" class="oemail">ten.tenih.7sm@auhnuhcw</a></span>.</div><div><a href="#idm140637379348848aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140637379348848_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2005 Mar 9; Accepted 2005 May 11.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140637379348848_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Wang et al. 2005</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1156954/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1_280" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1_280title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">During the acute phase of severe acute respiratory syndrome (SARS), mononuclear cells infiltration, alveolar cell desquamation and hyaline membrane formation have been described, together with dysregulation of plasma cytokine levels. Persistent high-resolution computed tomography (HRCT) abnormalities occur in SARS patients up to 40 days after recovery.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">To determine further the time course of recovery of lung inflammation, we investigated the HRCT and inflammatory profiles, and coronavirus persistence in bronchoalveolar lavage fluid (BALF) of 12 patients at recovery at 60 and 90 days.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">At 60 days, compared to normal controls, SARS patients had increased cellularity of BALF with increased alveolar macrophages (AM) and CD8 cells. HRCT scores were increased and correlated with T-cell numbers and their subpopulations, and inversely with CD4/CD8 ratio. TNF-&#x003b1;, IL-6, IL-8, RANTES and MCP-1 levels were increased. Viral particles in AM were detected by electron microscopy in 7 of 12 SARS patients with high HRCT score. On day 90, HRCT scores improved significantly in 10 of 12 patients, with normalization of BALF cell counts in 6 of 12 patients with repeat bronchoscopy. Pulse steroid therapy and prolonged fever were two independent factors associated with delayed resolution of pneumonitis, in this non-randomized, retrospective analysis.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">Resolution of pneumonitis is delayed in some patients during SARS recovery and may be associated with delayed clearance of coronavirus, Complete resolution may occur by 90 days or later.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">SARS, alveolar macrophages, T lymphocyte, coronavirus, cytokines, bronchoalveolar lavage</span></div></div><div id="Sec1_280" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1_280title">Introduction</h2><p id="__p5" class="p p-first">Severe acute respiratory syndrome (SARS) has affected more than 8 thousand patients in 22 countries causing 774 deaths between July 2002 and September 2003 [<a href="#CR1_280" rid="CR1_280" class=" bibr popnode">1</a>]. SARS-associated Coronavirus (SARS-CoV) has been identified as the causative agent [<a href="#CR2_280" rid="CR2_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324137">2</a>]. Typical clinical manifestations include fever, cough, dyspnea and rapid progression of pulmonary infiltration or consolidation [<a href="#CR3_280" rid="CR3_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324149">3</a>]. The mean mortality rate is 9.6% [<a href="#CR1_280" rid="CR1_280" class=" bibr popnode">1</a>], mostly attributed to hypoxemic respiratory failure. In the acute phase, typical pathological findings in the lungs include mononuclear cells infiltration, alveolar cell desquamation and hyaline membrane formation [<a href="#CR4_280" rid="CR4_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324160">4</a>]. Those mononuclear cells may develop into multinucleated giant cells [<a href="#CR4_280" rid="CR4_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324151">4</a>]. Proinflammatory cytokines released by alveolar macrophages may play a prominent role in the pathogenesis in SARS [<a href="#CR5_280" rid="CR5_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848473737">5</a>]. Marked elevation of inflammatory cytokines such as IL-1, IL-6 and IL-12, of the Th1 cytokine, IFN-&#x003b3;, and of chemokines IL-8, monocyte chemoattractant protein-1 (MCP-1), and IFN-&#x003b1;-induced protein-10 (IP-10) have been reported [<a href="#CR6_280" rid="CR6_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324153">6</a>]. High resolution Computed tomography (HRCT) findings at presentation include as unilateral or bilateral ground-glass opacities or focal unilateral or bilateral areas of consolidation [<a href="#CR7_280" rid="CR7_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324126">7</a>&#x02013;<a href="#CR9_280" rid="CR9_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324148">9</a>]. Such residual abnormalities have been described also after discharge from hospital at 36.5 days and at 6-months [<a href="#CR10_280" rid="CR10_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324152">10</a>, <a href="#CR11_280" rid="CR11_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324143">11</a>]. However, limited information is available on recovery of inflammatory abnormalities during recovery from SARS, particularly at 60 days and beyond..</p><p id="__p6" class="p p-last">In the current study, we conducted a study to examine HRCT changes in patients who recovered from the acute phase of SARS at days 60 and 90, and measured the associated inflammatory profiles directly by examining bronchoalveolar lavage fluid (BALF). We also examined the presence of coronavirus in BALF. We found persistence of HRCT abnormalities and of lung inflammation at day 60, and determined retrospectively the potential influence of pulse corticosteroid therapy in this process.</p></div><div id="Sec2_280" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2_280title">Methods</h2><div id="Sec3_280" class="sec sec-first"><h3 id="Sec3_280title">Study subjects</h3><p id="__p7" class="p p-first">Twelve (9 women and 3 men, aged 18 to 51 years) of 28 confirmed SARS patients who were treated in Chang Gung Memorial Hospital in Taiwan between April and May 2003 during the last epidemic of SARS in Taiwan, agreed to participate in this study. All the patients met the modified Centers for Disease Control and Prevention (CDC) case definition of SARS [<a href="#CR12_280" rid="CR12_280" class=" bibr popnode">12</a>]. SARS was confirmed by either positive real-time polymerase chain reaction (PCR) assays or elevated serum anti-coronavirus antibody by ELISA or both. Nasopharyngeal-aspirate samples were obtained from all study patients to exclude common viruses including influenza viruses A and B, respiratory syncytial (RSV) virus, adenovirus, and parainfluenzavirus types 1, 2, and 3, using commercially-available immunofluorescence assays (IFA). Sputum and blood cultures were performed on all the cases to exclude bacterial or fungal infections. At 90 days, all the close contact relatives of the study SARS patients had their serum anti-coronavirus antibody measured by ELISA.</p><p id="__p8" class="p p-last">Nine non-smoking healthy volunteers (5 women and 4 men, aged 18 to 40 years) without evident current or past history of pulmonary diseases based on history as well as physical, chest radiographic and bronchoscopic examinations were selected as controls for this study. None of them had any upper respiratory tract infection within the last 6 weeks or was on antibiotics or other medications at the time of evaluation.</p></div><div id="Sec4_280" class="sec"><h3 id="Sec4_280title">Study protocol</h3><p id="__p9" class="p p-first">The study protocol was approved by Chang Gung Memorial Hospital Ethical Committee. Informed consent was obtained from all the subjects. Treatment of SARS patients on admission to our unit included broad spectrum antibiotics to target common pathogens causing community-acquired pneumonia, according to current recommendations [<a href="#CR13_280" rid="CR13_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848473736">13</a>, <a href="#CR14_280" rid="CR14_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324144">14</a>]. These patients received variable therapy regimens, including oral ribavirin (1 g twice a day for 5&#x02013;7 days), or intravenous immunoglobulin (IVIG, 1 g/kg body weight/day for 2 days), pulse steroid therapy (methylprednisolone 500 mg twice a day for 3 days and then prednisolone 1 mg/kg body weight/day for 5 days), or maintenance corticosteroid therapy (prednisolone 10 mg twice a day for more than 3 weeks). Pulse steroid therapy was administered within 3 days of the onset of fever in some patients, depending on the attending physicians\' decision irrespective of severity of presentation. Some patients who did not receive pulse steroid therapy were given a short course of corticosteroid therapy (hydrocortisone 100 mg 3 times/day for 3 days) if there was rapid deterioration of pulmonary infiltration or hypoxemia. Maintenance steroid therapy (prednisolone 10 mg per day for one week) was given after pulse or short course corticosteroid therapy in all patients. Two patients were intubated with ventilator support because of hypoxemic respiratory failure.</p><p id="__p10" class="p p-last">Patients underwent HRCT and BAL on the 60<sup>th</sup> and 90<sup>th</sup> day after the onset of disease. HRCT was performed with 1- to 2-mm collimation sections reconstructed by the use of a high spatial frequency algorithm using a (General Electric Medical Systems, Milwaukee, WI). The HRCT protocol consisted of thin sections obtained at 10-mm through the chest in a supine position without using intravenous contrast medium.</p></div><div id="Sec5_280" class="sec"><h3 id="Sec5_280title">Scoring of HRCT findings</h3><p id="__p11" class="p p-first-last">The HRCT findings, as previously described [<a href="#CR9_280" rid="CR9_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324133">9</a>], were categorized the predominant pattern as: normal attenuation; ground glass opacification (hazy areas of increased attenuation without obscuration of the underlying vessels); consolidation (homogeneous opacification of the parenchyma with obscuration of the underlying vessels); reticular pattern; mixed pattern (combination of consolidation, ground glass opacities and reticular opacities in the presence of architectural distortion); ground-glass attenuation with traction bronchiolectasis or bronchiectasis; and honeycomb pattern. The extent of involvement of each abnormality was assessed independently for each of three zones: upper (above the carina), middle (below carina up to the inferior pulmonary vein), and lower (below the inferior pulmonary vein). Each lung zone (total of 6 lung zones) was assigned a score, modified from previously described [<a href="#CR9_280" rid="CR9_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324136">9</a>], based on the following: 0 when no involvement, 1 when &#x0003c;25% involvement, 2 when 25 &#x0003c;50% involvement; 3 when 50% &#x0003c;75% involvement and 4 when 75% involvement. Summation of scores provided overall lung involvement (maximal CT score 24). The grading of the patient\'s chest radiograph and HRCT was the consensus of two observers who were blind to clinical information of the patients.</p></div><div id="Sec6_280" class="sec"><h3 id="Sec6_280title">Fibreoptic bronchoscopy and BAL</h3><p id="__p12" class="p p-first-last">BAL was performed on all the study subjects using six aliquots (50 ml each) of 0.9% saline solution as described previously [<a href="#CR15_280" rid="CR15_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324132">15</a>]. Briefly, sterile saline solution was introduced into the subsegmental bronchus of the most severely involved lobe. The BAL fluid was retrieved and centrifuged. The supernatant was stored at -70&#x000b0;C until analysis and the cell pellet was washed and resuspended at 10<sup>6</sup> cells per ml. The cell viability and differential cell counts were determined. Total RNA and DNA were extracted from nasopharyngeal aspirates and cells retrieved by BAL with the Viral RNA minikit and QIAmp DNA minikit (QIAGEN, Hilden, Germany). Reverse-transcriptase (RT) PCR was done for influenza A, adenovirus, human metapneumovirus, and SARS-CoV as- described previously [<a href="#CR16_280" rid="CR16_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324129">16</a>].</p></div><div id="Sec7_280" class="sec"><h3 id="Sec7_280title">Measurement of T cell subpopulations by flow cytometric analysis</h3><p id="__p13" class="p p-first-last">BAL cells were simultaneously stained with fluorescein isothiocyanate or phycoerythrin-conjugated monoclonal antibodies (anti-IgG1, -IgG2a, -CD3, -CD4, -CD8, -CD19, -CD56) (Beckon Dickinson, Mountain View, CA) according to the manufacturer\'s protocol to identify the proportions of T lymphocytes, CD4, CD8 T cells, B cells and natural killer (NK) cells subpopulations respectively. The relative ratio of CD4 or CD8 in CD3-positive cells was assayed by a dual-color analysis. Data were acquired and analyzed using Becton Dickinson BD LYSYS II and Cytometric Bead Array (CBA) software (San Jose, CA).</p></div><div id="Sec8_280" class="sec"><h3 id="Sec8_280title">Levels of cytokine and chemokine in BAL fluid</h3><p id="__p14" class="p p-first-last">The levels of cytokines and chemokines in BAL fluid were assayed using Becton Dickinson (BD) Cytometric Bead Array&#x02122; [<a href="#CR17_280" rid="CR17_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324156">17</a>] (CBA; BD Biosciences, San Jose, CA) according to manufacturer\'s instructions with an antibody (PharMoingen, San Diego, CA) against one of five cytokines (Human Chemokine Kit I: CXCL8/IL-8, CCL5/RANTES, CXCL9/MIG, CCL2/MCP-1, CXCL10/IP-10, BD Biosciences,) or of the six cytokines (Human Inflammation Kit: IL-8, IL-1&#x003b2;, IL-6, IL-10, TNF-&#x003b1;, IL-12, BD Biosciences). Commercially available ELISA (R&#x00026;D Systems, Minneapolis) was used for measurement of the growth factors, TGF-&#x003b2;, IGF-1 and EGF.</p></div><div id="Sec9_280" class="sec"><h3 id="Sec9_280title">Electron microscopic (EM) examination</h3><p id="__p15" class="p p-first-last">We used a previously-described method for virus detection by electron microscopy [<a href="#CR18_280" rid="CR18_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324154">18</a>]. Cells retrieved by BAL from SARS patients and normal subjects were centrifuged. The cell pellets were fixed, embedded and stained with 4% tannic acid and 0.5% uranyl acetate. The ultra-thin sections were cut from Epon-embedded blocks, stained with uranyl acetate and lead citrate, and examined using a transmission electron microscope (TEM) (H-500, Hitachi, Tokyo, Japan).</p></div><div id="Sec10_280" class="sec sec-last"><h3 id="Sec10_280title">Statistical analysis</h3><p id="__p16" class="p p-first-last">Data are expressed as mean &#x000b1; SEM. The baseline characteristics, disease and laboratory variables between groups were compared using the two-tailed Student <em>t</em>-test and chi-square test, respectively. Spearman rank test was used to determine correlations between HRCT scores and T cell numbers, and their subpopulations, as well as CD4/CD8 ratio. Univariate analyses to determine the factors responsible for persistence of HRCT abnormalities were primarily used for selection of variables, based on a <em>p</em> value &#x0003c;0.05. The significant variables were entered into a stepwise logistic regression analysis to determine the net effect for each predictor while controlling of the others. A <em>p</em>-value &#x0003c;0.05 was considered as statistically significant. Analysis was performed using SPSS software version 10.0 (Chicago, IL, USA).</p></div></div><div id="Sec11_280" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec11_280title">Results</h2><div id="Sec12_280" class="sec sec-first"><h3 id="Sec12_280title">Study subjects</h3><p id="__p17" class="p p-first-last">28 patients with confirmed diagnosis of SARS were admitted during the study period. Sixteen patients received intubation and ventilatory support for respiratory failure. Three died of intractable hypoxemic respiratory failure. Twenty-five patients recovered subsequently and were discharged from the hospital. No patient relapsed with either fever or new pulmonary infiltrates after discharge from the hospital. Twenty of the 25 patients were randomly selected into the protocol and twelve agreed to participate. These patients complied with the protocol at 60 days but at 90 days, only 10 of 12 patients agreed to have a repeat HRCT, and 6 of 12 patients had a follow-up bronchoscopy.</p></div><div id="Sec13_280" class="sec"><h3 id="Sec13_280title">Clinical manifestations</h3><p id="__p18" class="p p-first-last">At 60 days, the commonest symptoms in SARS patients were general weakness (8 of 12 patients), exertional dyspnea (6 of 12 patients), joint pains (4 of 12 patients) and partial hair loss (11 of 12 patients). At 90 days, all the 12 SARS patients were well without any of the above-described symptoms. There was no detectable SARS-CoV antibody in the sera of close contact relatives of the study patients, even though SARS patients were not isolated after discharge from hospital from their close relatives.</p></div><div id="Sec14_280" class="sec"><h3 id="Sec14_280title">HRCT score</h3><p id="__p19" class="p p-first-last">At 60 days, 5 SARS patients were found with an HRCT abnormality of &#x0003c;10 % of the total lung field. In 3, the score was zero, in one ground glass attenuation was found in 7.5% of total lung field, and in another, there was consolidation in 1.7% of total lung field. The other 7 SARS patients had HRCT abnormality &#x0003e; 10% of each lung field (a mean of 37.5 &#x000b1; 7.9% involvement of total lung field) (Table <a href="/pmc/articles/PMC1156954/table/Tab1_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1_280" rid-ob="ob-Tab1_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). The most prominent HRCT findings in these patients were ground-glass attenuation (80.8 &#x000b1; 12.2% of total abnormality on HRCT) and consolidation (13.6 &#x000b1; 10.9% of total abnormality on HRCT). Honeycombing and bronchiectatic changes were found in only 3 SARS patients with high HRCT score (5.5 &#x000b1; 2.7% of total abnormality on HRCT). Seven of 11 patients were found normal on their follow-up HRCT at 90 days (Table <a href="/pmc/articles/PMC1156954/table/Tab2_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2_280" rid-ob="ob-Tab2_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2;</span></span><span>2</span></a>; Figure <a href="/pmc/articles/PMC1156954/figure/Fig1_280/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1_280" rid-ob="ob-Fig1_280" co-legend-rid="lgnd_Fig1_280"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure1).</span></span><span>1</span></a>). Two of the patients had persistently high HRCT scores (Table <a href="/pmc/articles/PMC1156954/table/Tab1_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1_280" rid-ob="ob-Tab1_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). One with very high HRCT score at 60 days refused a follow-up HRCT.\n\n\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1_280"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p20">Individual HRCT score at 60 and 90 days, and electron microscopic findings in patients with SARS</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140637379912800" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="center" colspan="2" rowspan="1">HRCT score</th><th align="center" colspan="2" rowspan="1">Virus particle in AM by EM</th></tr><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">60 days</th><th align="center" rowspan="1" colspan="1">90 days</th><th align="center" rowspan="1" colspan="1">60 days</th><th align="center" rowspan="1" colspan="1">90 days</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Case 1</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">N/D</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 2</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">N/D</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">N/D</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">N/D</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 5</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">N/D</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 6</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 7</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">N/D</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 8</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 9</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 10</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 11</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">N/D</td></tr><tr><td align="center" rowspan="1" colspan="1">Case 12</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">N/D</td><td align="center" rowspan="1" colspan="1">+</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">Mean &#x000b1; SE</td><td align="center" rowspan="1" colspan="1">8.8 &#x000b1; 2.1</td><td align="center" rowspan="1" colspan="1">2.4 &#x000b1; 1.3*</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140637379912800" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1156954/table/Tab1_280/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p21"><strong>Abbreviation:</strong> HRCT, high resolution computed tomography; SARS, severe acute respiratory syndrome; AM, alveolar macrophage; EM, electron microscopy; N/D, not done.</p><p id="__p22"><em>p</em> &#x0003c; 0.01 indicates a comparison of HRCT score between 60 days and 90 days in corresponding group.</p></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab2_280"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p23">Univariate and multivariate analysis: predictors based on presence of virus particle and lung involvement in patients with SARS.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140637375717648" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Factor</th><th align="center" rowspan="1" colspan="1">Low HRCT score and Absence of virus particle<br />(n = 5)<br />no. (%)</th><th align="center" rowspan="1" colspan="1">High HRCT score and Presence of virus particle<br />(n = 7)<br />no. (%)</th><th align="center" colspan="3" rowspan="1">Univariate analysis</th><th align="center" rowspan="1" colspan="1">Multivariate analysis</th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">\n<strong><em>P</em></strong>\n<strong>value</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong>Odd ratio</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong>95% confidence interval</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong><em>P</em></strong>\n<strong>value</strong>\n</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, year</td><td align="center" rowspan="1" colspan="1">25.6 &#x000b1; 4.2</td><td align="center" rowspan="1" colspan="1">34.9 &#x000b1; 2.9</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Female gender</td><td align="center" rowspan="1" colspan="1">5 (100%)</td><td align="center" rowspan="1" colspan="1">4 (57.1%)</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">1.75</td><td align="center" rowspan="1" colspan="1">0.92&#x02013;3.32</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Titer of Anti-CoV IgG (OD) *</td><td align="center" rowspan="1" colspan="1">0.8 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">1.3 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Days of fever</td><td align="center" rowspan="1" colspan="1">4.2 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">11.0 &#x000b1; 1.0</td><td align="center" rowspan="1" colspan="1">0.0003</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.011</td></tr><tr><td align="left" rowspan="1" colspan="1">Positive PCR</td><td align="center" rowspan="1" colspan="1">2 (28.6%)</td><td align="center" rowspan="1" colspan="1">5 (71.4%)</td><td align="center" rowspan="1" colspan="1">0.276</td><td align="center" rowspan="1" colspan="1">3.75</td><td align="center" rowspan="1" colspan="1">0.33&#x02013;42.47</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of ribavirin</td><td align="center" rowspan="1" colspan="1">4 (57.1%)</td><td align="center" rowspan="1" colspan="1">6 (85.7%)</td><td align="center" rowspan="1" colspan="1">0.79</td><td align="center" rowspan="1" colspan="1">1.50</td><td align="center" rowspan="1" colspan="1">0.71&#x02013;31.58</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of IVIG</td><td align="center" rowspan="1" colspan="1">4 (57.1%)</td><td align="center" rowspan="1" colspan="1">6 (85.7%)</td><td align="center" rowspan="1" colspan="1">0.79</td><td align="center" rowspan="1" colspan="1">1.50</td><td align="center" rowspan="1" colspan="1">0.71&#x02013;31.58</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulse corticosteroid therapy</td><td align="center" rowspan="1" colspan="1">0 (0%)</td><td align="center" rowspan="1" colspan="1">4 (57.1%)</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">2.33</td><td align="center" rowspan="1" colspan="1">0.99&#x02013;5.49</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">Maintenance corticosteroid therapy</td><td align="center" rowspan="1" colspan="1">0 (0%)</td><td align="center" rowspan="1" colspan="1">3 (42.9%)</td><td align="center" rowspan="1" colspan="1">0.09</td><td align="center" rowspan="1" colspan="1">1.75</td><td align="center" rowspan="1" colspan="1">0.92&#x02013;3.32</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Need for intubation</td><td align="center" rowspan="1" colspan="1">1 (14.3%)</td><td align="center" rowspan="1" colspan="1">1 (14.3%)</td><td align="center" rowspan="1" colspan="1">0.79</td><td align="center" rowspan="1" colspan="1">0.67</td><td align="center" rowspan="1" colspan="1">0.03&#x02013;14.03</td><td align="center" rowspan="1" colspan="1">-</td></tr></tbody></table></div><div id="largeobj_idm140637375717648" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1156954/table/Tab2_280/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p24"><strong>Abbreviation:</strong> HRCT, high resolution computed tomography; SARS, severe acute respiratory syndrome; IVIG, intravenous immunoglobulin; CoV, coronavirus; OD, optical density; PCR, polymerase chain reaction. Data are shown as mean &#x000b1; SEM.</p><p id="__p25">*The cut value of positive SARS infection is 0.12 OD.</p></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1_280" co-legend-rid="lgnd_Fig1_280"><a href="/pmc/articles/PMC1156954/figure/Fig1_280/" target="figure" rid-figpopup="Fig1_280" rid-ob="ob-Fig1_280"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140637387940912" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12931_2005_280_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12931_2005_280_Fig1_HTML.jpg" src="/pmc/articles/PMC1156954/bin/12931_2005_280_Fig1_HTML.jpg" /></div><div id="largeobj_idm140637387940912" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1156954/figure/Fig1_280/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1_280"><div><a class="figpopup" href="/pmc/articles/PMC1156954/figure/Fig1_280/" target="figure" rid-figpopup="Fig1_280" rid-ob="ob-Fig1_280">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p26">Residual abnormality on HRCT of a SARS patient with high HRCT score at 60 days (A). HRCT became almost normal at 90 days (B).</p></div></div></div></div><div id="Sec15_280" class="sec"><h3 id="Sec15_280title">Factors associated with residual HRCT abnormalities at day 60</h3><p id="__p27" class="p p-first-last">The residual abnormality on HRCT at 60 days was related to the clinical course. Univariate analysis identified 3 factors associated with the residual abnormality on HRCT. There were a greater proportion of patients receiving pulse steroid therapy (4 of 7) in patients with high HRCT score (Table <a href="/pmc/articles/PMC1156954/table/Tab2_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2_280" rid-ob="ob-Tab2_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). In contrast, none of the patients with low HRCT score received pulse steroid therapy (Table <a href="/pmc/articles/PMC1156954/table/Tab2_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2_280" rid-ob="ob-Tab2_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). There was no significant difference in other therapy, including maintenance or short course corticosteroid therapy, IVIG or ribavirin, between patients with high HRCT score and those with low HRCT score (Table <a href="/pmc/articles/PMC1156954/table/Tab2_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2_280" rid-ob="ob-Tab2_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2).</span></span><span>2</span></a>). Patients with high HRCT score had significantly longer course of fever and higher serum SARS-CoV antibody titer when compared to those in patients with low HRCT score (Table <a href="/pmc/articles/PMC1156954/table/Tab2_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2_280" rid-ob="ob-Tab2_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2</span></span><span>2</span></a>).</p></div><div id="Sec16_280" class="sec"><h3 id="Sec16_280title">Inflammatory profiles of BAL fluid</h3><p id="__p28" class="p p-first-last">At 60 days, compared to normal subjects, there was a significant increase in total cell counts in BAL fluid from SARS patients (Table <a href="/pmc/articles/PMC1156954/table/Tab3_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3_280" rid-ob="ob-Tab3_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3)</span></span><span>3</span></a>) with a significant increase in alveolar macrophages (AM) and lymphocytes., The proportion of CD8+ T cells was increased to a greater extent than CD4+ T cells, leading to a significant decrease in CD4/CD8 ratio (Table <a href="/pmc/articles/PMC1156954/table/Tab4_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4_280" rid-ob="ob-Tab4_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table4).</span></span><span>4</span></a>). There was also a significant increase in the proportion of NK cells in SARS patients (Table <a href="/pmc/articles/PMC1156954/table/Tab4_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4_280" rid-ob="ob-Tab4_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table4).</span></span><span>4</span></a>). There was no significant difference in B lymphocytes between SARS patients with low or high HRCT scores and normal subjects. HRCT scores were highly correlated with the cell counts of total lymphocyte, CD4+ and CD8+ T cells, and inversely related to the CD4/CD8 ratio (Figure <a href="/pmc/articles/PMC1156954/figure/Fig2_280/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2_280" rid-ob="ob-Fig2_280" co-legend-rid="lgnd_Fig2_280"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2).</span></span><span>2</span></a>). At 90 days, the cellular profiles in BAL fluid of 6 SARS patients were significantly improved compared with those at 60 days, with near normalization (Tables <a href="/pmc/articles/PMC1156954/table/Tab3_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3_280" rid-ob="ob-Tab3_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Tables3,</span></span><span>3</span></a>, <a href="/pmc/articles/PMC1156954/table/Tab4_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4_280" rid-ob="ob-Tab4_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0.5em;">,4</span></span><span>4</span></a>).\n\n\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab3_280"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p29">Characteristics of bronchoalveolar lavage in normal subjects and patients with SARS</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140637380907168" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">Normal subjects</th><th align="center" colspan="2" rowspan="1">SARS patients</th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">\n<strong>60 days</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong>90 days</strong>\n</th></tr><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">\n<strong>(n = 9)</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong>(n = 12)</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong>(n = 6)</strong>\n</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">24.1 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">34.0 &#x000b1; 2.7*</td><td align="center" rowspan="1" colspan="1">36.6 &#x000b1; 3.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Female gender</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Cellularity (10<sup>4</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">9.6 &#x000b1; 0.9</td><td align="center" rowspan="1" colspan="1">32.9 &#x000b1; 9.0*</td><td align="center" rowspan="1" colspan="1">26.2 &#x000b1; 9.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Cell viability (%)</td><td align="center" rowspan="1" colspan="1">91.5 &#x000b1; 4.3</td><td align="center" rowspan="1" colspan="1">90.4 &#x000b1; 1.3</td><td align="center" rowspan="1" colspan="1">91.6 &#x000b1; 1.8</td></tr><tr><td align="left" rowspan="1" colspan="1">AM (%)</td><td align="center" rowspan="1" colspan="1">93.2 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">88.8 &#x000b1; 1.2*</td><td align="center" rowspan="1" colspan="1">95.0 &#x000b1; 0.6&#x02020;</td></tr><tr><td align="left" rowspan="1" colspan="1">AM (10<sup>4</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">8.9 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">29.0 &#x000b1; 7.8*</td><td align="center" rowspan="1" colspan="1">25.1 &#x000b1; 9.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocytes (%)</td><td align="center" rowspan="1" colspan="1">5.9 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">10.2 &#x000b1; 1.2*</td><td align="center" rowspan="1" colspan="1">4.1 &#x000b1; 0.5&#x02020;</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocytes (10<sup>4</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">0.6 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">3.8 &#x000b1; 1.2*</td><td align="center" rowspan="1" colspan="1">1.0 &#x000b1; 0.2&#x02020;</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutrophils (%)</td><td align="center" rowspan="1" colspan="1">0.9 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">0.7 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">0.9 &#x000b1; 0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutrophils (10<sup>4</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">0.1 &#x000b1; 0.02</td><td align="center" rowspan="1" colspan="1">0.2 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">0.2 &#x000b1; 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Eosinophils (%)</td><td align="center" rowspan="1" colspan="1">0.1 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">0.3 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">0.0 &#x000b1; 0.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Eosinophils (10<sup>4</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">0.01 &#x000b1; 0.01</td><td align="center" rowspan="1" colspan="1">0.05 &#x000b1; 0.04</td><td align="center" rowspan="1" colspan="1">0.0 &#x000b1; 0.0</td></tr></tbody></table></div><div id="largeobj_idm140637380907168" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1156954/table/Tab3_280/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p30"><strong>Abbreviation:</strong> AM, alveolar macrophages; HRCT, high resolution computed tomography; SARS, severe acute respiratory syndrome.</p><p id="__p31">*<em>p</em> &#x0003c; 0.01 compared with normal subjects.</p><p id="__p32">&#x02020; <em>p</em> &#x0003c; 0.05 compared with SARS patients at 60 days.</p><p id="__p33">Data are mean &#x000b1; SEM.</p></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab4_280"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p34">Lymphocyte subpopulations in bronchoalveolar lavage from normal subjects and patients with SARS</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140637377788592" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">Normal subjects</th><th align="center" colspan="2" rowspan="1">SARS patients</th></tr><tr><th rowspan="1" colspan="1"></th><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">\n<strong>60 days</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong>90 days</strong>\n</th></tr><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">\n<strong>(n = 9)</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong>(n = 12)</strong>\n</th><th align="center" rowspan="1" colspan="1">\n<strong>(n = 6)</strong>\n</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Lymphocytes (10<sup>3</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">5.8 &#x000b1; 1.4</td><td align="center" rowspan="1" colspan="1">39.2 &#x000b1; 12.1*</td><td align="center" rowspan="1" colspan="1">9.7 &#x000b1; 2.4<sup>&#x02020;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">CD3 cells (%)</td><td align="center" rowspan="1" colspan="1">39.7 &#x000b1; 6.4</td><td align="center" rowspan="1" colspan="1">33.1 &#x000b1; 6.7</td><td align="center" rowspan="1" colspan="1">37.8 &#x000b1; 6.1</td></tr><tr><td align="left" rowspan="1" colspan="1">CD3 cells (10<sup>3</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">2.4 &#x000b1; 0.5</td><td align="center" rowspan="1" colspan="1">16.3 &#x000b1; 6.4*</td><td align="center" rowspan="1" colspan="1">3.3 &#x000b1; 0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">CD4 cells (%)</td><td align="center" rowspan="1" colspan="1">9.2 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">8.7 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">10.4 &#x000b1; 4.3</td></tr><tr><td align="left" rowspan="1" colspan="1">CD4 cells (10<sup>3</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">1.2 &#x000b1; 0.3</td><td align="center" rowspan="1" colspan="1">4.4 &#x000b1; 2.0*</td><td align="center" rowspan="1" colspan="1">0.8 &#x000b1; 0.3</td></tr><tr><td align="left" rowspan="1" colspan="1">CD8 cells (%)</td><td align="center" rowspan="1" colspan="1">6.6 &#x000b1; 2.6</td><td align="center" rowspan="1" colspan="1">20.1 &#x000b1; 5.5*</td><td align="center" rowspan="1" colspan="1">13.2 &#x000b1; 3.3</td></tr><tr><td align="left" rowspan="1" colspan="1">CD8 cells (10<sup>3</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">0.7 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">11.8 &#x000b1; 4.7*</td><td align="center" rowspan="1" colspan="1">1.1 &#x000b1; 0.2<sup>&#x02020;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">CD4/CD8 (ratio)</td><td align="center" rowspan="1" colspan="1">1.89 &#x000b1; 0.22</td><td align="center" rowspan="1" colspan="1">0.62 &#x000b1; 0.12*</td><td align="center" rowspan="1" colspan="1">0.73 &#x000b1; 0.12<sup>&#x02020;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">B cells (%)</td><td align="center" rowspan="1" colspan="1">6.7 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">3.2 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">2.8 &#x000b1; 0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">B cells (10<sup>3</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">0.4 &#x000b1; 0.1</td><td align="center" rowspan="1" colspan="1">1.4 &#x000b1; 0.7</td><td align="center" rowspan="1" colspan="1">0.3 &#x000b1; 0.1</td></tr><tr><td align="left" rowspan="1" colspan="1">NK cells (%)</td><td align="center" rowspan="1" colspan="1">1.8 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">8.8 &#x000b1; 2.6*</td><td align="center" rowspan="1" colspan="1">5.8 &#x000b1; 2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">NK cells (10<sup>3</sup> cells/ml)</td><td align="center" rowspan="1" colspan="1">0.1 &#x000b1; 0.03</td><td align="center" rowspan="1" colspan="1">4.0 &#x000b1; 2.4**</td><td align="center" rowspan="1" colspan="1">0.3 &#x000b1; 0.1<sup>&#x02020;</sup>\n</td></tr></tbody></table></div><div id="largeobj_idm140637377788592" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1156954/table/Tab4_280/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p35"><strong>Abbreviation:</strong> HRCT, high resolution computed tomography; NK, natural killer.</p><p id="__p36">*<em>p</em> &#x0003c; 0.05, ** <em>p</em> &#x0003c; 0.01 compared with normal subjects.</p><p id="__p37">&#x02020;<em>p</em> &#x0003c; 0.05 compared with SARS patients at 60 days.</p><p id="__p38">Data are mean &#x000b1; SEM.</p></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2_280" co-legend-rid="lgnd_Fig2_280"><a href="/pmc/articles/PMC1156954/figure/Fig2_280/" target="figure" rid-figpopup="Fig2_280" rid-ob="ob-Fig2_280"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140637375379872" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12931_2005_280_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12931_2005_280_Fig2_HTML.jpg" src="/pmc/articles/PMC1156954/bin/12931_2005_280_Fig2_HTML.jpg" /></div><div id="largeobj_idm140637375379872" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1156954/figure/Fig2_280/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2_280"><div><a class="figpopup" href="/pmc/articles/PMC1156954/figure/Fig2_280/" target="figure" rid-figpopup="Fig2_280" rid-ob="ob-Fig2_280">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p39">Correlation of the cell counts of (A) total lymphocytes, (B) CD4 and (C) CD8 T cells, or the (D) CD4/CD8 ratio with HRCT scores in SARS patients. The analysis is made by Spearman rank test and the number and significance are indicated.</p></div></div></div></div><div id="Sec17_280" class="sec"><h3 id="Sec17_280title">Cytokine and chemokine level in BAL fluid</h3><p id="__p40" class="p p-first-last">At 60 days, SARS patients had a significantly higher level of chemokines, IL-8, MCP-1, and RANTES (Table <a href="/pmc/articles/PMC1156954/table/Tab5_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab5_280" rid-ob="ob-Tab5_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table5),</span></span><span>5</span></a>), and of pro-inflammatory cytokines, TNF-&#x003b1; and IL-6. However, the growth factors, transforming growth factor-&#x003b2; (TGF-&#x003b2;), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), were not increased (Table <a href="/pmc/articles/PMC1156954/table/Tab5_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab5_280" rid-ob="ob-Tab5_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table5</span></span><span>5</span></a>).\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab5_280"><h3>Table 5</h3><!--caption a7--><div class="caption"><p id="__p41">Cytokine and chemokine levels in bronchoalveolar lavage from normal subjects and SARS patients</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140637389183584" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">Normal subjects (n = 9)</th><th align="center" rowspan="1" colspan="1">SARS patients (n = 12)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CXCL10/IP-10 (pg/ml)</td><td align="center" rowspan="1" colspan="1">95.8 &#x000b1; 25.7</td><td align="center" rowspan="1" colspan="1">133.1 &#x000b1; 37.5</td></tr><tr><td align="left" rowspan="1" colspan="1">CXCL9/MIG (pg/ml)</td><td align="center" rowspan="1" colspan="1">20.2 &#x000b1; 6.5</td><td align="center" rowspan="1" colspan="1">53.1 &#x000b1; 14.1*</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-8 (pg/ml)</td><td align="center" rowspan="1" colspan="1">1.5 &#x000b1; 0.2</td><td align="center" rowspan="1" colspan="1">6.3 &#x000b1; 1.0**</td></tr><tr><td align="left" rowspan="1" colspan="1">CCL2/MCP-1 (pg/ml)</td><td align="center" rowspan="1" colspan="1">2.4 &#x000b1; 0.8</td><td align="center" rowspan="1" colspan="1">9.0 &#x000b1; 1.2**</td></tr><tr><td align="left" rowspan="1" colspan="1">CCL5/RANTES (pg/ml)</td><td align="center" rowspan="1" colspan="1">1.0 &#x000b1; 0.4</td><td align="center" rowspan="1" colspan="1">34.6 &#x000b1; 9.3**</td></tr><tr><td align="left" rowspan="1" colspan="1">TNF-&#x003b1; (pg/ml)</td><td align="center" rowspan="1" colspan="1">0.004 &#x000b1; 0.002</td><td align="center" rowspan="1" colspan="1">1.1 &#x000b1; 0.3*</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-1&#x003b2; (pg/ml)</td><td align="center" rowspan="1" colspan="1">0.00 &#x000b1; 0.00</td><td align="center" rowspan="1" colspan="1">2.5 &#x000b1; 1.8</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-6 (pg/ml)</td><td align="center" rowspan="1" colspan="1">0.001 &#x000b1; 0.001</td><td align="center" rowspan="1" colspan="1">1.7 &#x000b1; 0.5**</td></tr><tr><td align="left" rowspan="1" colspan="1">IFN-&#x003b3; (pg/ml)</td><td align="center" rowspan="1" colspan="1">0.0 &#x000b1; 0.0</td><td align="center" rowspan="1" colspan="1">0.4 &#x000b1; 0.3</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-2 (pg/ml)</td><td align="center" rowspan="1" colspan="1">0.00 &#x000b1; 0.00</td><td align="center" rowspan="1" colspan="1">0.4 &#x000b1; 0.2</td></tr><tr><td align="left" rowspan="1" colspan="1">TGF-&#x003b2; (pg/ml)</td><td align="center" rowspan="1" colspan="1">9.6 &#x000b1; 2.9</td><td align="center" rowspan="1" colspan="1">15.4 &#x000b1; 4.6</td></tr><tr><td align="left" rowspan="1" colspan="1">IGF-1 (ng/ml)</td><td align="center" rowspan="1" colspan="1">0.06 &#x000b1; 0.03</td><td align="center" rowspan="1" colspan="1">0.07 &#x000b1; 0.05</td></tr><tr><td align="left" rowspan="1" colspan="1">EGF (pg/ml)</td><td align="center" rowspan="1" colspan="1">0.0 &#x000b1; 0.0</td><td align="center" rowspan="1" colspan="1">0.0 &#x000b1; 0.0</td></tr></tbody></table></div><div id="largeobj_idm140637389183584" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1156954/table/Tab5_280/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p42">* <em>p</em> &#x0003c; 0.05, ** <em>p</em> &#x0003c; 0.01 compared with normal subjects.</p><p id="__p43">Data are shown as mean &#x000b1; SEM.</p></div></div></div><div id="Sec18_280" class="sec sec-last"><h3 id="Sec18_280title">Virus detection</h3><p id="__p44" class="p p-first">The 12 enrolled patients had serological evidence of recent infection with the SARS-CoV and in seven, viral RNA was detected in samples taken from nasopharyngeal aspirate or stool. However, viral RNA was not detectable in the stool or nasopharyngeal aspirate of any of the SARS patients at 60 days. Healthy controls had no evidence of SARS-CoV antibody or RNA in the serum or the respiratory tract. There were no detectable common viruses including influenza viruses A and B, RSV virus, adenovirus, human metapneumovirus, and parainfluenzavirus types 1, 2, and 3, using IFA for nasopharyngeal aspirates or using RT-PCR assay for cells retrieved by BAL at 60 or 90 days. Serological studies for <em>Clamydia, Mycoplasma</em> or <em>Legionella</em> were negative in all subjects.</p><p id="__p45" class="p p-last">At 60 days, EM examination of BAL fluid revealed many coronavirus-infected alveolar macrophages with intracellular viral particles in 7 of 12 patients (Figure <a href="/pmc/articles/PMC1156954/figure/Fig3_280/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3_280" rid-ob="ob-Fig3_280" co-legend-rid="lgnd_Fig3_280"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3;</span></span><span>3</span></a>; Table <a href="/pmc/articles/PMC1156954/table/Tab1_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1_280" rid-ob="ob-Tab1_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1).</span></span><span>1</span></a>). These patients had the high HRCT scan scores. Coronavirus infected cells were not detected in any of SARS patients with low HRCT score or in normal subjects (Table <a href="/pmc/articles/PMC1156954/table/Tab1_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1_280" rid-ob="ob-Tab1_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). RT-PCR amplification of coronavirus nucleic acids was positive in 3 of 7 patients with high HRCT score, but in none of patients with low HRCT score or normal subjects. At 90 days, EM examination did not detect any coronavirus-infected cells in 6 SARS patients, in 5 of the 6, viral inclusions were found in AM at day 60 (Table <a href="/pmc/articles/PMC1156954/table/Tab1_280/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1_280" rid-ob="ob-Tab1_280" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). One patient with persistent high HRCT score (case 12) refused follow-up BAL study at 90 days.\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3_280" co-legend-rid="lgnd_Fig3_280"><a href="/pmc/articles/PMC1156954/figure/Fig3_280/" target="figure" rid-figpopup="Fig3_280" rid-ob="ob-Fig3_280"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140637373857600" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12931_2005_280_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12931_2005_280_Fig3_HTML.jpg" src="/pmc/articles/PMC1156954/bin/12931_2005_280_Fig3_HTML.jpg" /></div><div id="largeobj_idm140637373857600" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1156954/figure/Fig3_280/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3_280"><div><a class="figpopup" href="/pmc/articles/PMC1156954/figure/Fig3_280/" target="figure" rid-figpopup="Fig3_280" rid-ob="ob-Fig3_280">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p46">Ultrastructural characteristics of a Coronavirus-Infected cell in BAL fluid from a SARS patient at 60 days, with several intracellular particles. The virions are indicated by the arrowheads in Panel A. Panel B shows the area indicated by the asterisk in Panel A at higher magnification. The bar in Panel A (500 nm) and Panel B (100 nm) is indicated.</p></div></div></div></div></div><div id="Sec19_280" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec19_280title">Discussion</h2><p id="__p47" class="p p-first">This study was performed during the last epidemic of SARS in Taiwan, and the number of patients recruited has been limited. The epidemic did not recur during 2004, and there have been no further cases of SARS in Taiwan, such that we were not able to increase the number of patients in this study. Despite the relatively low numbers, our observations indicate that there are persistent important inflammatory and radiological abnormalities in some patients who have recovered from acute SARS at 60 days after the illness. These changes were those of ground-glass or/and consolidation abnormalities which may be overlooked on examination of plain chest radiographs. The BAL fluid examination performed for the first time in recovering SARS patients confirmed the presence of an on-going active inflammatory process in most patients with increased macrophages, NK cells and T cells, and augmented levels of chemokines and pro-inflammatory cytokines. These inflammatory responses may be elicited by the persistent presence of coronavirus in alveolar macrophages, since the patients with the highest HRCT changes had coronaviruses present and there was no evidence of bacterial or other viral infection in these patients.</p><p id="__p48">Most viral diseases are characterized by the development of a specific infiltration consisting predominantly of mononuclear leukocytes while neutrophils are absent [<a href="#CR19_280" rid="CR19_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324145">19</a>]. The most striking features of alveolar inflammation in patients were increased numbers of alveolar macrophages, T lymphocytes and NK cells, with a striking decrease in CD4/CD8 ratio. The HRCT score was highly correlated with T lymphocyte numbers and their subpopulations, and was inversely related to CD4/CD8 ratio. CD8+ T cells may act as cytotoxic cells and are key effectors of virus clearance [<a href="#CR20_280" rid="CR20_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324157">20</a>]. The concurrent increase in CD4+ T cells may promote the clonal expansion of virus-specific CD8+ T cells and is essential for maintaining continued CD8+ T cells surveillance and effector capacity [<a href="#CR19_280" rid="CR19_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324138">19</a>].</p><p id="__p49">Exposure of monocytes or macrophages to viruses causes the release of proinflammatory cytokines, such as TNF-&#x003b1;, IL-1, and IL-6, and chemokines [<a href="#CR20_280" rid="CR20_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324158">20</a>&#x02013;<a href="#CR22_280" rid="CR22_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324130">22</a>] as well as members of the CC-chemokine subfamily such as MIP-l&#x003b1;, MCP-1, and RANTES which preferentially attract monocytes and lymphocytes [<a href="#CR22_280" rid="CR22_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324146">22</a>]. The CXC-chemokines, such as IL-8 or GRO-&#x003b1;, are major neutrophil chemoattractants [<a href="#CR23_280" rid="CR23_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324139">23</a>]. MIG/CXC chemokine ligand (CXCL) 9 and IP-10/CXCL10, both inducible by interferon-&#x003b3;, are ELR-negative CXC chemokines and are potent chemoattractants for mononuclear cells, specifically activated T lymphocytes and NK cells [<a href="#CR24_280" rid="CR24_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324155">24</a>]. In this report, we demonstrated elevated levels of TNF-&#x003b1;, IL-6, MCP-1, RANTES and IL-8 in BAL fluid in SARS patients compared to those of normal subjects. Increased secretion of TNF-&#x003b1; and IL-6 may be derived from virus-infected macrophages or from CD4+ or CD8+ T cells, and these cytokines may promote T-lymphocyte extravasation and macrophage activation [<a href="#CR19_280" rid="CR19_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324128">19</a>], but such processes may not be sufficient on their own to recruit and activate mononuclear cells in virus-infected lungs. The increased levels of MCP-1 and RANTES in BAL fluid of all SARS patients may be responsible for the generation of mononuclear infiltrates observed after coronavirus infection. IP-10 and MIG, whose levels are also increase in SARS patients, recruit monocytes and macrophages, NK cells and activated, but not resting T lymphocytes [<a href="#CR25_280" rid="CR25_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324142">25</a>, <a href="#CR26_280" rid="CR26_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324131">26</a>].</p><p id="__p50">Although there were increased levels of IL-8 in BAL fluid in SARS patients, the number of neutrophils in BALF were sparse. The absence of neutrophil infiltration in influenza A virus or respiratory syncytial viruses (RSV) infection is attributed to the suppression of neutrophil attracting CXC-chemokines or by induction of IL-10 [<a href="#CR27_280" rid="CR27_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324125">27</a>]. However, IL-8 production can be induced by measles virus infection of fibroblasts [<a href="#CR28_280" rid="CR28_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324147">28</a>] and by influenza A virus, RSV and rhinovirus in pulmonary epithelial cells or AM [<a href="#CR28_280" rid="CR28_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324135">28</a>&#x02013;<a href="#CR31_280" rid="CR31_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324150">31</a>]. The reasons for the lack of neutrophil recruitment in response to elevated IL-8 levels in SARS patients are not known and this deserves further investigation.</p><p id="__p51">Despite the presence of virus in AM at 60 days when patients had already been discharged from hospital, these patients were not infectious, because none of their close contact relatives developed any detectable SARS-CoV antibody in their sera. The HRCT and the clinical course until the 90th day of illness did not suggest any evidence of pulmonary fibrosis in SARS patients. This was in accord with the low level of cytokines and growth factors responsible for tissue repairing and fibrosis [<a href="#CR32_280" rid="CR32_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324159">32</a>], such as IL-1&#x003b2;, TGF-&#x003b2;, IGF-1, and EGF detected in BAL fluid. However, evidence of fibrosis on HRCT has been obtained on HRCT scans particularly in patients with very severe disease during the acute phase of SARS [<a href="#CR33_280" rid="CR33_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324134">33</a>].</p><p id="__p52">The use of corticosteroids together with ribavirin has been reported to confer clinical benefit, although randomized clinical trials to support its clinical efficacy are not available. Pulse steroid therapy was reported to lead to less oxygen requirement, better radiographic outcome, and less likelihood to require rescue pulse steroid therapy than their counterparts [<a href="#CR34_280" rid="CR34_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324161">34</a>]. However, corticosteroids have been shown to increase mortality of pneumovirus-infected mice by accelerating replication of virus [<a href="#CR35_280" rid="CR35_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324140">35</a>]. Pulse steroid therapy was also reported to be associated with residual abnormality on HRCT in SARS patients after discharge from hospital [<a href="#CR10_280" rid="CR10_280" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845324141">10</a>]. In the current retrospective, non-randomized series, pulse steroid therapy appeared to be associated with delayed resolution of pneumonitis. We have planned a prospective future study on investigating the effect of pulse steroid therapy in case of future outbreaks of SARS. This is because this issue is extremely important in outcome from SARS.</p><p id="__p53" class="p p-last">In conclusion, a proportion of recovered SARS patients have delayed resolution of pneumonitis and delayed clearance of coronavirus in the alveolar space at day 60. This was associated with persistent inflammatory response characterized by macrophages, T cells particularly CD8+ T cells, and NK cells, and by increase in cytokines and chemokines. This host inflammatory response against SARS-CoV infection may contribute to persistent HRCT abnormalities during recovery phase of SARS. On the other hand, we found no evidence of pulmonary fibrosis in SARS patients during recovery. At day 90, many of the abnormalities have disappeared. Patients recovering from SARS need to be followed up for at least 3 months after the infection.</p></div><div id="idm140637377115632" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140637377115632title">Acknowledgements</h2><div class="sec"><p id="__p54">This project was supported by CMRP-32012S from Chang Gung Memorial Hospital.</p></div></div><div id="idm140637379348848aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140637379348848aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Chun-Hua Wang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.tenih.7sm@auhnuhcw" class="oemail">ten.tenih.7sm@auhnuhcw</a></span>.</p><p><span class="fm-affl">Chien-Ying Liu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.tenih.asm@uil.yneihc" class="oemail">ten.tenih.asm@uil.yneihc</a></span>.</p><p><span class="fm-affl">Yung-Liang Wan, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="wt.gro.hmgc.mda@8150wly" class="oemail">wt.gro.hmgc.mda@8150wly</a></span>.</p><p><span class="fm-affl">Chun-Liang Chou, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.nsm@6362uohcrd" class="oemail">moc.nsm@6362uohcrd</a></span>.</p><p><span class="fm-affl">Kuo-Hsiung Huang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="wt.ten.dees@685shk" class="oemail">wt.ten.dees@685shk</a></span>.</p><p><span class="fm-affl">Horng-Chyuan Lin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.tenih.31sm@42435nil" class="oemail">ten.tenih.31sm@42435nil</a></span>.</p><p><span class="fm-affl">Shu-Min Lin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.tenqraps@001nilms" class="oemail">ten.tenqraps@001nilms</a></span>.</p><p><span class="fm-affl">Tzou-Yien Lin, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="wt.gro.hmgc.mda@nildip" class="oemail">wt.gro.hmgc.mda@nildip</a></span>.</p><p><span class="fm-affl">Kian Fan Chung, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lairepmi@gnuhc.f" class="oemail">ku.ca.lairepmi@gnuhc.f</a></span>.</p><p><span class="fm-affl">Han-Pin Kuo, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.tenih.11sm@8288q" class="oemail">ten.tenih.11sm@8288q</a></span>.</p></div><div id="Bib1_280" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1_280title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1_280">1. <span class="mixed-citation"><strong>Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS)</strong>\n[<a href="http://www.who.int/csr/sars/country/en/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/csr/sars/country/en/</a>]\n<em>Geneva: World Health Organization</em> 2003. Accessed September 26, 2003</span></div><div class="ref-cit-blk half_rhythm" id="CR2_280">2. <span class="element-citation">Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ, SARS Working Group  A Novel coronavirus associated with severe acute respiratory syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1953\xe2\x80\x931966. doi: 10.1056/NEJMoa030781.</span> [<a href="/pubmed/12690092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa030781" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+Novel+coronavirus+associated+with+severe+acute+respiratory+syndrome&amp;author=TG+Ksiazek&amp;author=D+Erdman&amp;author=CS+Goldsmith&amp;author=SR+Zaki&amp;author=T+Peret&amp;volume=348&amp;publication_year=2003&amp;pages=1953-1966&amp;pmid=12690092&amp;doi=10.1056/NEJMoa030781&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3_280">3. <span class="element-citation">Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, Tellier R, Draker R, Adachi D, Ayers M, Chan AK, Skowronski DM, Salit I, Simor AE, Slutsky AS, Doyle PW, Krajden M, Petric M, Brunham RC, McGeer AJ, National Microbiology Laboratory, Canada; Canadian Severe Acute Respiratory Syndrome Study Team  Identification of severe acute respiratory syndrome in Canada. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1993\xe2\x80\x932003. doi: 10.1056/NEJMoa030634.</span> [<a href="/pubmed/12671061" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa030634" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Identification+of+severe+acute+respiratory+syndrome+in+Canada&amp;author=SM+Poutanen&amp;author=DE+Low&amp;author=B+Henry&amp;author=S+Finkelstein&amp;author=D+Rose&amp;volume=348&amp;publication_year=2003&amp;pages=1993-2003&amp;doi=10.1056/NEJMoa030634&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4_280">4. <span class="element-citation">Tse GMK, To KF, Chan PKS, Lo AWI, Ng KC, Wu A, Lee N, Wong HC, Mak SM, Chan KF, Hui DSC, Sung JJY, Ng HK. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS) <span><span class="ref-journal">J Clin Pathol. </span>2004;<span class="ref-vol">57</span>:260\xe2\x80\x93265. doi: 10.1136/jcp.2003.013276.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1770245/">PMC free article</a>]</span> [<a href="/pubmed/14990596" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fjcp.2003.013276" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pathol&amp;title=Pulmonary+pathological+features+in+coronavirus+associated+severe+acute+respiratory+syndrome+(SARS)&amp;author=GMK+Tse&amp;author=KF+To&amp;author=PKS+Chan&amp;author=AWI+Lo&amp;author=KC+Ng&amp;volume=57&amp;publication_year=2004&amp;pages=260-265&amp;pmid=14990596&amp;doi=10.1136/jcp.2003.013276&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5_280">5. <span class="element-citation">Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS. Lung pathology of fatal severe acute respiratory syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:1773\xe2\x80\x931778. doi: 10.1016/S0140-6736(03)13413-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112492/">PMC free article</a>]</span> [<a href="/pubmed/12781536" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(03)13413-7" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Lung+pathology+of+fatal+severe+acute+respiratory+syndrome&amp;author=JM+Nicholls&amp;author=LL+Poon&amp;author=KC+Lee&amp;author=WF+Ng&amp;author=ST+Lai&amp;volume=361&amp;publication_year=2003&amp;pages=1773-1778&amp;pmid=12781536&amp;doi=10.1016/S0140-6736(03)13413-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6_280">6. <span class="element-citation">Wong CK, Lam CWK, Wu AKL, Ip WK, Lee NLS, Chan HIS, Lit LCW, Hui DSC, Chan MHM, Chung SSC, Sung IJY. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. <span><span class="ref-journal">Clin Exp Immunol. </span>2004;<span class="ref-vol">136</span>:95\xe2\x80\x93103. doi: 10.1111/j.1365-2249.2004.02415.x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1808997/">PMC free article</a>]</span> [<a href="/pubmed/15030519" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1365-2249.2004.02415.x" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Immunol&amp;title=Plasma+inflammatory+cytokines+and+chemokines+in+severe+acute+respiratory+syndrome&amp;author=CK+Wong&amp;author=CWK+Lam&amp;author=AKL+Wu&amp;author=WK+Ip&amp;author=NLS+Lee&amp;volume=136&amp;publication_year=2004&amp;pages=95-103&amp;pmid=15030519&amp;doi=10.1111/j.1365-2249.2004.02415.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7_280">7. <span class="element-citation">Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung, Lam WK, Seto WH, Yam LY, Cheung TM, Wong PC, Lam B, Ip MS, Chan J, Yuen KY, Lai KN. A cluster of cases of severe acute respiratory syndrome in Hong Kong. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1977\xe2\x80\x931985. doi: 10.1056/NEJMoa030666.</span> [<a href="/pubmed/12671062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa030666" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+cluster+of+cases+of+severe+acute+respiratory+syndrome+in+Hong+Kong&amp;author=KW+Tsang&amp;author=PL+Ho&amp;author=GC+Ooi&amp;author=WK+Yee&amp;author=T+Wang&amp;volume=348&amp;publication_year=2003&amp;pages=1977-1985&amp;pmid=12671062&amp;doi=10.1056/NEJMoa030666&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8_280">8. <span class="element-citation">Muller NL, Ooi GC, Khong PL, Zhou LJ, Tsang KWT, Nicolaou S. High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission. <span><span class="ref-journal">AJR. </span>2004;<span class="ref-vol">182</span>:39\xe2\x80\x9344. doi: 10.2214/ajr.182.1.1820039.</span> [<a href="/pubmed/14684509" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2214%2Fajr.182.1.1820039" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AJR&amp;title=High-resolution+CT+findings+of+severe+acute+respiratory+syndrome+at+presentation+and+after+admission&amp;author=NL+Muller&amp;author=GC+Ooi&amp;author=PL+Khong&amp;author=LJ+Zhou&amp;author=KWT+Tsang&amp;volume=182&amp;publication_year=2004&amp;pages=39-44&amp;pmid=14684509&amp;doi=10.2214/ajr.182.1.1820039&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9_280">9. <span class="element-citation">Ooi GC, Khong PL, Muller NL, Yiu WC, Zhou LJ, Ho JCM, Lam B, Nicolaou S, Tsang KW. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. <span><span class="ref-journal">Radiology. </span>2004;<span class="ref-vol">230</span>:839\xe2\x80\x93844. doi: 10.1148/radiol.2303030853.</span> [<a href="/pubmed/14990845" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1148%2Fradiol.2303030853" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Severe+acute+respiratory+syndrome:+temporal+lung+changes+at+thin-section+CT+in+30+patients&amp;author=GC+Ooi&amp;author=PL+Khong&amp;author=NL+Muller&amp;author=WC+Yiu&amp;author=LJ+Zhou&amp;volume=230&amp;publication_year=2004&amp;pages=839-844&amp;doi=10.1148/radiol.2303030853&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10_280">10. <span class="element-citation">Antonio GE, Wong KT, Hui DS, Wu A, Lee N, Yuen EH, Leung CB, Rainer TH, Cameron P, Chung SS, Sung JJ, Ahuja AT. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. <span><span class="ref-journal">Radiology. </span>2003;<span class="ref-vol">228</span>:810\xe2\x80\x93815. doi: 10.1148/radiol.2283030726.</span> [<a href="/pubmed/12805557" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1148%2Fradiol.2283030726" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Thin-section+CT+in+patients+with+severe+acute+respiratory+syndrome+following+hospital+discharge:+preliminary+experience&amp;author=GE+Antonio&amp;author=KT+Wong&amp;author=DS+Hui&amp;author=A+Wu&amp;author=N+Lee&amp;volume=228&amp;publication_year=2003&amp;pages=810-815&amp;pmid=12805557&amp;doi=10.1148/radiol.2283030726&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11_280">11. <span class="element-citation">Ng CK, Chan JW, Kwan TL, To TS, Chan YH, Ng FY, Mok TY.  <span class="ref-journal">Thorax.</span> 2004. Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1746851/">PMC free article</a>]</span> [<a href="/pubmed/15454656" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Thorax&amp;author=CK+Ng&amp;author=JW+Chan&amp;author=TL+Kwan&amp;author=TS+To&amp;author=YH+Chan&amp;publication_year=2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12_280">12. <span class="element-citation">Centers for Disease Control and Prevention  . <span class="ref-journal">Severe acute respiratory syndrome (SARS) updated interim US case definition.</span> 2003.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Severe+acute+respiratory+syndrome+(SARS)+updated+interim+US+case+definition&amp;publication_year=2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13_280">13. <span class="element-citation">Bartlett JG, Dowell SF, Mandell LA, File TM, Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. <span><span class="ref-journal">Clin Infect Dis. </span>2000;<span class="ref-vol">31</span>:347\xe2\x80\x93382. doi: 10.1086/313954.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7109923/">PMC free article</a>]</span> [<a href="/pubmed/10987697" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F313954" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Practice+guidelines+for+the+management+of+community-acquired+pneumonia+in+adults&amp;author=JG+Bartlett&amp;author=SF+Dowell&amp;author=LA+Mandell&amp;author=TM+File&amp;author=DM+Musher&amp;volume=31&amp;publication_year=2000&amp;pages=347-382&amp;pmid=10987697&amp;doi=10.1086/313954&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14_280">14. <span class="mixed-citation"><strong>Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention</strong><em>Am J Respir Crit Care Med</em> 2001, <strong>163:</strong>1730&#x02013;1754. [<a href="/pubmed/11401897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR15_280">15. <span class="element-citation">Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible nitric oxide synthase upregulation in alveolar macrophages. <span><span class="ref-journal">Eur Respir J. </span>1998;<span class="ref-vol">11</span>:809\xe2\x80\x93815. doi: 10.1183/09031936.98.11040809.</span> [<a href="/pubmed/9623681" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1183%2F09031936.98.11040809" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&amp;title=Increased+exhaled+nitric+oxide+in+active+pulmonary+tuberculosis+due+to+inducible+nitric+oxide+synthase+upregulation+in+alveolar+macrophages&amp;author=CH+Wang&amp;author=CY+Liu&amp;author=HC+Lin&amp;author=CT+Yu&amp;author=KF+Chung&amp;volume=11&amp;publication_year=1998&amp;pages=809-815&amp;pmid=9623681&amp;doi=10.1183/09031936.98.11040809&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16_280">16. <span class="element-citation">Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, Gunther S. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. <span><span class="ref-journal">J Clin Microbiol. </span>2002;<span class="ref-vol">40</span>:2323\xe2\x80\x932330. doi: 10.1128/JCM.40.7.2323-2330.2002.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC120575/">PMC free article</a>]</span> [<a href="/pubmed/12089242" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJCM.40.7.2323-2330.2002" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Rapid+detection+and+quantification+of+RNA+of+Ebola+and+Marburg+viruses,+Lassa+virus,+Crimean-Congo+hemorrhagic+fever+virus,+Rift+Valley+fever+virus,+dengue+virus,+and+yellow+fever+virus+by+real-time+reverse+transcription-PCR&amp;author=C+Drosten&amp;author=S+Gottig&amp;author=S+Schilling&amp;author=M+Asper&amp;author=M+Panning&amp;volume=40&amp;publication_year=2002&amp;pages=2323-2330&amp;pmid=12089242&amp;doi=10.1128/JCM.40.7.2323-2330.2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17_280">17. <span class="element-citation">Aoe K, Hiraki A, Murakami T, Murakami K, Makihata K, Takao K, Eda R, Maeda T, Sugi K, Darzynkiewicz Z, Takeyama H. Relative abundance and patterns of correlation among six cytokines in pleural fluid measured by cytometric bead array. <span><span class="ref-journal">Int J Mol Med. </span>2003;<span class="ref-vol">12</span>:193\xe2\x80\x93198.</span> [<a href="/pubmed/12851716" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Med&amp;title=Relative+abundance+and+patterns+of+correlation+among+six+cytokines+in+pleural+fluid+measured+by+cytometric+bead+array&amp;author=K+Aoe&amp;author=A+Hiraki&amp;author=T+Murakami&amp;author=K+Murakami&amp;author=K+Makihata&amp;volume=12&amp;publication_year=2003&amp;pages=193-198&amp;pmid=12851716&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18_280">18. <span class="element-citation">Wu S, Ko YS, Teng MS, Ko YL, Hsu LA, Hsueh C, Chou YY, Liew CC, Lee YS. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. <span><span class="ref-journal">J Mol Cell Cardiol. </span>2002;<span class="ref-vol">34</span>:1595\xe2\x80\x931607. doi: 10.1006/jmcc.2002.2110.</span> [<a href="/pubmed/12505058" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1006%2Fjmcc.2002.2110" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Mol+Cell+Cardiol&amp;title=Adriamycin-induced+cardiomyocyte+and+endothelial+cell+apoptosis:+in+vitro+and+in+vivo+studies&amp;author=S+Wu&amp;author=YS+Ko&amp;author=MS+Teng&amp;author=YL+Ko&amp;author=LA+Hsu&amp;volume=34&amp;publication_year=2002&amp;pages=1595-1607&amp;pmid=12505058&amp;doi=10.1006/jmcc.2002.2110&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19_280">19. <span class="element-citation">Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. <span><span class="ref-journal">Immunol Rev. </span>1997;<span class="ref-vol">159</span>:105\xe2\x80\x93117. doi: 10.1111/j.1600-065X.1997.tb01010.x.</span> [<a href="/pubmed/9416506" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1600-065X.1997.tb01010.x" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Rev&amp;title=Effector+CD4++and+CD8++T-cell+mechanisms+in+the+control+of+respiratory+virus+infections&amp;author=PC+Doherty&amp;author=DJ+Topham&amp;author=RA+Tripp&amp;author=RD+Cardin&amp;author=JW+Brooks&amp;volume=159&amp;publication_year=1997&amp;pages=105-117&amp;pmid=9416506&amp;doi=10.1111/j.1600-065X.1997.tb01010.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20_280">20. <span class="element-citation">Nain M, Hinder F, Gong JH, Schmidt A, Bender A, Sprenger H, Gemsa D. Tumor necrosis factor-&#x003b1; production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. <span><span class="ref-journal">J Immunol. </span>1990;<span class="ref-vol">145</span>:1921\xe2\x80\x931928.</span> [<a href="/pubmed/2391423" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Tumor+necrosis+factor-&#x003b1;+production+of+influenza+A+virus-infected+macrophages+and+potentiating+effect+of+lipopolysaccharides&amp;author=M+Nain&amp;author=F+Hinder&amp;author=JH+Gong&amp;author=A+Schmidt&amp;author=A+Bender&amp;volume=145&amp;publication_year=1990&amp;pages=1921-1928&amp;pmid=2391423&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21_280">21. <span class="element-citation">Gong JH, Sprenger H, Hinder F, Bender A, Schmidt A, Horch S, Nain M, Gemsa D. Influenza A virus infection of macrophages: enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. <span><span class="ref-journal">J Immunol. </span>1991;<span class="ref-vol">147</span>:3507\xe2\x80\x933513.</span> [<a href="/pubmed/1940351" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Influenza+A+virus+infection+of+macrophages:+enhanced+tumor+necrosis+factor-alpha+(TNF-alpha)+gene+expression+and+lipopolysaccharide-triggered+TNF-alpha+release&amp;author=JH+Gong&amp;author=H+Sprenger&amp;author=F+Hinder&amp;author=A+Bender&amp;author=A+Schmidt&amp;volume=147&amp;publication_year=1991&amp;pages=3507-3513&amp;pmid=1940351&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22_280">22. <span class="element-citation">Henke A, Mohr C, Sprenger H, Graebner C, Stelzner A, Nain M, Gemsa D. Coxsackievirus B3-induced production of tumor necrosis factor-&#x003b1;, IL-1, and IL-6 in human monocytes. <span><span class="ref-journal">J Immunol. </span>1992;<span class="ref-vol">148</span>:2270\xe2\x80\x932277.</span> [<a href="/pubmed/1312105" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Coxsackievirus+B3-induced+production+of+tumor+necrosis+factor-&#x003b1;,+IL-1,+and+IL-6+in+human+monocytes&amp;author=A+Henke&amp;author=C+Mohr&amp;author=H+Sprenger&amp;author=C+Graebner&amp;author=A+Stelzner&amp;volume=148&amp;publication_year=1992&amp;pages=2270-2277&amp;pmid=1312105&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23_280">23. <span class="element-citation">Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. <span><span class="ref-journal">Annu Rev Immunol. </span>1991;<span class="ref-vol">9</span>:617\xe2\x80\x93648. doi: 10.1146/annurev.iy.09.040191.003153.</span> [<a href="/pubmed/1910690" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1146%2Fannurev.iy.09.040191.003153" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;title=Properties+of+the+novel+proinflammatory+supergene+&quot;intercrine&quot;+cytokine+family&amp;author=JJ+Oppenheim&amp;author=COC+Zachariae&amp;author=N+Mukaida&amp;author=K+Matsushima&amp;volume=9&amp;publication_year=1991&amp;pages=617-648&amp;pmid=1910690&amp;doi=10.1146/annurev.iy.09.040191.003153&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24_280">24. <span class="element-citation">Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines &#x02013; CXC and CC chemokines. <span><span class="ref-journal">Adv lmmunol. </span>1994;<span class="ref-vol">55</span>:97\xe2\x80\x93179. doi: 10.1016/S0065-2776(08)60509-X.</span> [<a href="/pubmed/8304236" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0065-2776(08)60509-X" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv+lmmunol&amp;title=Interleukin-8+and+related+chemotactic+cytokines+&#x02013;+CXC+and+CC+chemokines&amp;author=M+Baggiolini&amp;author=B+Dewald&amp;author=B+Moser&amp;volume=55&amp;publication_year=1994&amp;pages=97-179&amp;doi=10.1016/S0065-2776(08)60509-X&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25_280">25. <span class="element-citation">Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP-10 and Mig: structure, function and expression in activated T lymphocytes. <span><span class="ref-journal">J Exp Med. </span>1996;<span class="ref-vol">184</span>:963\xe2\x80\x93969. doi: 10.1084/jem.184.3.963.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2192763/">PMC free article</a>]</span> [<a href="/pubmed/9064356" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1084%2Fjem.184.3.963" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Chemokine+receptor+specific+for+IP-10+and+Mig:+structure,+function+and+expression+in+activated+T+lymphocytes&amp;author=M+Loetscher&amp;author=B+Gerber&amp;author=P+Loetscher&amp;author=SA+Jones&amp;author=L+Piali&amp;volume=184&amp;publication_year=1996&amp;pages=963-969&amp;pmid=9064356&amp;doi=10.1084/jem.184.3.963&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26_280">26. <span class="element-citation">Arai K, Liu ZX, Lane T, Dennert G. IP-10 and MIG facilitate accumulation of T cells in the virus-infected liver. <span><span class="ref-journal">Cell Immunol. </span>2002;<span class="ref-vol">219</span>:48\xe2\x80\x9356. doi: 10.1016/S0008-8749(02)00584-1.</span> [<a href="/pubmed/12473267" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0008-8749(02)00584-1" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Immunol&amp;title=IP-10+and+MIG+facilitate+accumulation+of+T+cells+in+the+virus-infected+liver&amp;author=K+Arai&amp;author=ZX+Liu&amp;author=T+Lane&amp;author=G+Dennert&amp;volume=219&amp;publication_year=2002&amp;pages=48-56&amp;pmid=12473267&amp;doi=10.1016/S0008-8749(02)00584-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27_280">27. <span class="element-citation">Panuska JR, Merolla R, Rebert NA, Hoffmann SP, Tsivitse P, Cirino NM, Silverman RH, Rankin JA. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. <span><span class="ref-journal">J Clin Invest. </span>1995;<span class="ref-vol">96</span>:2445\xe2\x80\x932453. doi: 10.1172/JCI118302.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC185897/">PMC free article</a>]</span> [<a href="/pubmed/7593633" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1172%2FJCI118302" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Respiratory+syncytial+virus+induces+interleukin-10+by+human+alveolar+macrophages.+Suppression+of+early+cytokine+production+and+implications+for+incomplete+immunity&amp;author=JR+Panuska&amp;author=R+Merolla&amp;author=NA+Rebert&amp;author=SP+Hoffmann&amp;author=P+Tsivitse&amp;volume=96&amp;publication_year=1995&amp;pages=2445-2453&amp;pmid=7593633&amp;doi=10.1172/JCI118302&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28_280">28. <span class="element-citation">Van Damme J, Decock B, Conings R, Falkenburg JH, Opdenakker G, Billiau A. The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8. <span><span class="ref-journal">Eur J Immunol. </span>1989;<span class="ref-vol">19</span>:1189\xe2\x80\x931194. doi: 10.1002/eji.1830190706.</span> [<a href="/pubmed/2668011" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Feji.1830190706" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol&amp;title=The+chemotactic+activity+for+granulocytes+produced+by+virally+infected+fibroblasts+is+identical+to+monocyte-derived+interleukin+8&amp;author=J+Van+Damme&amp;author=B+Decock&amp;author=R+Conings&amp;author=JH+Falkenburg&amp;author=G+Opdenakker&amp;volume=19&amp;publication_year=1989&amp;pages=1189-1194&amp;pmid=2668011&amp;doi=10.1002/eji.1830190706&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29_280">29. <span class="element-citation">Choi AMK, Jacoby DB. Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. <span><span class="ref-journal">FEBS Lett. </span>1992;<span class="ref-vol">309</span>:327\xe2\x80\x93329. doi: 10.1016/0014-5793(92)80799-M.</span> [<a href="/pubmed/1516705" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0014-5793(92)80799-M" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=Influenza+virus+A+infection+induces+interleukin-8+gene+expression+in+human+airway+epithelial+cells&amp;author=AMK+Choi&amp;author=DB+Jacoby&amp;volume=309&amp;publication_year=1992&amp;pages=327-329&amp;pmid=1516705&amp;doi=10.1016/0014-5793(92)80799-M&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30_280">30. <span class="element-citation">Becker S, Quay J, Soukoup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. <span><span class="ref-journal">J Immunol. </span>1991;<span class="ref-vol">147</span>:4307\xe2\x80\x934312.</span> [<a href="/pubmed/1753101" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Cytokine+(tumor+necrosis+factor,+IL-6,+and+IL-8)+production+by+respiratory+syncytial+virus-infected+human+alveolar+macrophages&amp;author=S+Becker&amp;author=J+Quay&amp;author=J+Soukoup&amp;volume=147&amp;publication_year=1991&amp;pages=4307-4312&amp;pmid=1753101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31_280">31. <span class="element-citation">Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovims. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. <span><span class="ref-journal">J Clin Invest. </span>1995;<span class="ref-vol">96</span>:549\xe2\x80\x93557. doi: 10.1172/JCI118067.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC185229/">PMC free article</a>]</span> [<a href="/pubmed/7615827" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1172%2FJCI118067" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Infection+of+a+human+respiratory+epithelial+cell+line+with+rhinovims.+Induction+of+cytokine+release+and+modulation+of+susceptibility+to+infection+by+cytokine+exposure&amp;author=MC+Subauste&amp;author=DB+Jacoby&amp;author=SM+Richards&amp;author=D+Proud&amp;volume=96&amp;publication_year=1995&amp;pages=549-557&amp;pmid=7615827&amp;doi=10.1172/JCI118067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32_280">32. <span class="element-citation">Kelly M, Kolb M, Bonniaud P, Gauldie J. Re-evaluation of fibrogenic cytokines in lung fibrosis. <span><span class="ref-journal">Curr Pharm Des. </span>2003;<span class="ref-vol">9</span>:39\xe2\x80\x9349. doi: 10.2174/1381612033392341.</span> [<a href="/pubmed/12570673" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2174%2F1381612033392341" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Pharm+Des&amp;title=Re-evaluation+of+fibrogenic+cytokines+in+lung+fibrosis&amp;author=M+Kelly&amp;author=M+Kolb&amp;author=P+Bonniaud&amp;author=J+Gauldie&amp;volume=9&amp;publication_year=2003&amp;pages=39-49&amp;pmid=12570673&amp;doi=10.2174/1381612033392341&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33_280">33. <span class="element-citation">Muller NL, Ooi GC, Khong PL, Zhou LJ, Tsang KW, Nicolaou S. High-resolution CT findings of severe acute respiratory syndrome at presentation and after admission. <span><span class="ref-journal">Am J Roentgenol. </span>2004;<span class="ref-vol">182</span>:39\xe2\x80\x9344. doi: 10.2214/ajr.182.1.1820039.</span> [<a href="/pubmed/14684509" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2214%2Fajr.182.1.1820039" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Roentgenol&amp;title=High-resolution+CT+findings+of+severe+acute+respiratory+syndrome+at+presentation+and+after+admission&amp;author=NL+Muller&amp;author=GC+Ooi&amp;author=PL+Khong&amp;author=LJ+Zhou&amp;author=KW+Tsang&amp;volume=182&amp;publication_year=2004&amp;pages=39-44&amp;pmid=14684509&amp;doi=10.2214/ajr.182.1.1820039&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34_280">34. <span class="element-citation">Ho JC, Ooi GC, Mok TY, Chan JW, Hung I, Lam B, Wong PC, Li PC, Ho PL, Lam WK, Ng CK, Ip MS, Lai KN, Chan-Yeung M, Tsang KW. High dose versus non-pulse corticosteroid regimens in severe acute respiratory syndrome. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2003;<span class="ref-vol">168</span>:1449\xe2\x80\x931456. doi: 10.1164/rccm.200306-766OC.</span> [<a href="/pubmed/12947028" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200306-766OC" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=High+dose+versus+non-pulse+corticosteroid+regimens+in+severe+acute+respiratory+syndrome&amp;author=JC+Ho&amp;author=GC+Ooi&amp;author=TY+Mok&amp;author=JW+Chan&amp;author=I+Hung&amp;volume=168&amp;publication_year=2003&amp;pages=1449-1456&amp;pmid=12947028&amp;doi=10.1164/rccm.200306-766OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35_280">35. <span class="element-citation">Domachowske JB, Bonville CA, Ali-Ahmad D, Rosenberg HF. Glucocorticoid administration accelerate mortality of pneumovirus-infected mice. <span><span class="ref-journal">J Infect Dis. </span>2001;<span class="ref-vol">184</span>:1518\xe2\x80\x931523. doi: 10.1086/324664.</span> [<a href="/pubmed/11740726" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F324664" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Glucocorticoid+administration+accelerate+mortality+of+pneumovirus-infected+mice&amp;author=JB+Domachowske&amp;author=CA+Bonville&amp;author=D+Ali-Ahmad&amp;author=HF+Rosenberg&amp;volume=184&amp;publication_year=2001&amp;pages=1518-1523&amp;pmid=11740726&amp;doi=10.1086/324664&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1156954&amp;issue-id=354895&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1156954/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1156954/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1156954/pdf/12931_2005_Article_280.pdf">PDF (3.3M)</a></li> | <li><a href="#" data-citationid="PMC1156954" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1156954%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1156954%2F&amp;text=Persistence%20of%20lung%20inflammation%20and%20lung%20cytokines%20with%20high-resolution%20CT%20abnormalities%20during%20recovery%20from%20SARS"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1156954%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="15888207" data-aiid="7099891" data-aid="1156954" data-iid="354895" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC1156954" data-md5="d62642dc03c512e344eee78ae764e984"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:07:52-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BF459E999783100000000095D095C&amp;ncbi_session=8A1BF459E99AA281_2397SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1156954%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1156954/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BF459E99AA281_2397SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'